Share this post on:

Product Name: Galectin-13 antibody [PP13/1165]
Applications: IHC-P
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration:
Purification: Ab purified from Bioreactor Concentrate by Protein A/G
Full Name: lectin, galactoside-binding, soluble, 13
Background: Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene has lysophospholipase activity. It is composed of two identical subunits which are held together by disulfide bonds. This protein has structural similarity to several members of the beta-galactoside-binding S-type lectin family. [provided by RefSeq, Jul 2008]
Synonyms: lectin, galactoside-binding, soluble, 13 Antibody , PLAC8 Antibody , PP13 Antibody , GAL13 Antibody , LGALS13 Antibody
Cellular Localization:
CAS NO: 54767-75-8
Product: Imipramine (hydrochloride)
Host: Mouse
Clonality: Monoclonal
Isotype: IgG2b
Immunogen: Recombinant human Galectin-13 protein fragment (aa23-134) (exact sequence is proprietary)
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: Prepared in 1mM PBS with 0.05% BSA and 0.05% azide.
Storage Instruction:
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: It recognizes a 32kDa protein, which is identified as homodimer of galectin-13 (also known as PP13). Galectins are a family of soluble β-galactoside-binding lectins that modulate cell-to-cell adhesion and cell-to-extracellular matrix (ECM) interactions and play a role in tumor progression, pre-mRNA splicing and apoptosis. One such member, galectin-13, is a 139 amino acid protein that contains one galectin domain. Possessing lysophospholipase activity, galectin-13 exists as a disulfide-linked homodimer. Galectin-13 is suggested to have a developmental role in the placenta and may display immunobiological activity in feto-maternal blood-spaces. Screening for galectin-13 in maternal serum during the first trimester of pregnancy may serve as a diagnostic marker to predict preterm pre-eclampsia.
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/25893775?dopt=Abstract

Share this post on: